USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: AuraSense Therapeutics LLC
City: Skokie
State: IL
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,295.00 1
SBIR Phase II $986,621.00 1

Award List:

Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency / Branch: DOD / DARPA
Principal Investigator: David Giljohann, Chief Scientific Officer – (847) 467-2887
Award Amount: $149,295.00
Abstract:
AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called spherical nucleic acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. AuraSense Therapeutics will use SNAs as genetically programmable antimicrobial agents in a manner to… More

Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency / Branch: DOD / DARPA
Principal Investigator: David Giljohann, COO – (847) 673-1702
Award Amount: $986,621.00
Abstract:
AuraSense Therapeutics is developing oligonucleotide-modified gold nanoparticles called Spherical Nucleic Acid (SNA) constructs, which are a powerful new way of regulating cellular gene expression. AuraSense Therapeutics will use SNAs as genetically programmable antimicrobial agents in a manner to… More